nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLC22A1—prostate cancer	0.115	0.408	CbGaD
Quinidine—CYP2E1—prostate cancer	0.064	0.226	CbGaD
Quinidine—CYP1A1—prostate cancer	0.0631	0.223	CbGaD
Quinidine—CYP3A4—prostate cancer	0.0403	0.143	CbGaD
Quinidine—ORM1—Abiraterone—prostate cancer	0.0271	0.0578	CbGbCtD
Quinidine—ABCB11—Ethinyl Estradiol—prostate cancer	0.0224	0.0478	CbGbCtD
Quinidine—SLCO1A2—Estrone—prostate cancer	0.0159	0.034	CbGbCtD
Quinidine—SLCO1B1—Cabazitaxel—prostate cancer	0.0154	0.0328	CbGbCtD
Quinidine—CYP1A1—Flutamide—prostate cancer	0.0152	0.0326	CbGbCtD
Quinidine—SLCO1B1—Estrone—prostate cancer	0.015	0.0321	CbGbCtD
Quinidine—ABCC2—Ethinyl Estradiol—prostate cancer	0.0118	0.0251	CbGbCtD
Quinidine—CYP1A1—Estrone—prostate cancer	0.011	0.0235	CbGbCtD
Quinidine—CYP2C8—Nilutamide—prostate cancer	0.0106	0.0227	CbGbCtD
Quinidine—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0104	0.0223	CbGbCtD
Quinidine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.00983	0.021	CbGbCtD
Quinidine—SLC22A2—Estradiol—prostate cancer	0.00929	0.0198	CbGbCtD
Quinidine—SLCO1A2—Estradiol—prostate cancer	0.00915	0.0195	CbGbCtD
Quinidine—SLC22A8—Conjugated Estrogens—prostate cancer	0.00908	0.0194	CbGbCtD
Quinidine—CYP2C8—Abiraterone—prostate cancer	0.0088	0.0188	CbGbCtD
Quinidine—ABCC2—Conjugated Estrogens—prostate cancer	0.00864	0.0184	CbGbCtD
Quinidine—SLCO1B1—Estradiol—prostate cancer	0.00863	0.0184	CbGbCtD
Quinidine—CYP2E1—Estrone—prostate cancer	0.00851	0.0182	CbGbCtD
Quinidine—CYP2B6—Estrone—prostate cancer	0.0084	0.0179	CbGbCtD
Quinidine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0082	0.0175	CbGbCtD
Quinidine—SLC22A1—Estradiol—prostate cancer	0.00807	0.0172	CbGbCtD
Quinidine—SLC22A8—Estradiol—prostate cancer	0.00797	0.017	CbGbCtD
Quinidine—SLCO1A2—Prednisone—prostate cancer	0.00787	0.0168	CbGbCtD
Quinidine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00749	0.016	CbGbCtD
Quinidine—CYP2C9—Bicalutamide—prostate cancer	0.00741	0.0158	CbGbCtD
Quinidine—CYP2C9—Nilutamide—prostate cancer	0.00741	0.0158	CbGbCtD
Quinidine—CYP1A2—Flutamide—prostate cancer	0.00681	0.0145	CbGbCtD
Quinidine—CYP2D6—Bicalutamide—prostate cancer	0.00677	0.0145	CbGbCtD
Quinidine—ABCB1—Estramustine—prostate cancer	0.00668	0.0143	CbGbCtD
Quinidine—CYP2C8—Cabazitaxel—prostate cancer	0.00651	0.0139	CbGbCtD
Quinidine—ABCB11—Doxorubicin—prostate cancer	0.00643	0.0137	CbGbCtD
Quinidine—CYP1A1—Estradiol—prostate cancer	0.00633	0.0135	CbGbCtD
Quinidine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00567	0.0121	CbGbCtD
Quinidine—CYP2D6—Abiraterone—prostate cancer	0.00561	0.012	CbGbCtD
Quinidine—CYP3A7—Estradiol—prostate cancer	0.00507	0.0108	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00507	0.0108	CbGbCtD
Quinidine—CYP2E1—Mitoxantrone—prostate cancer	0.00506	0.0108	CbGbCtD
Quinidine—ABCC2—Etoposide—prostate cancer	0.00495	0.0106	CbGbCtD
Quinidine—CYP1A2—Estrone—prostate cancer	0.00492	0.0105	CbGbCtD
Quinidine—ABCC2—Docetaxel—prostate cancer	0.00453	0.00968	CbGbCtD
Quinidine—CYP2C9—Estrone—prostate cancer	0.00444	0.00947	CbGbCtD
Quinidine—ABCB1—Cabazitaxel—prostate cancer	0.00441	0.00941	CbGbCtD
Quinidine—CYP3A4—Bicalutamide—prostate cancer	0.00431	0.00919	CbGbCtD
Quinidine—ABCB1—Estrone—prostate cancer	0.00431	0.00919	CbGbCtD
Quinidine—CYP3A4—Estramustine—prostate cancer	0.004	0.00855	CbGbCtD
Quinidine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00384	0.00819	CbGbCtD
Quinidine—CYP2C8—Estradiol—prostate cancer	0.00365	0.0078	CbGbCtD
Quinidine—CYP3A4—Abiraterone—prostate cancer	0.00357	0.00762	CbGbCtD
Quinidine—CYP3A4—Flutamide—prostate cancer	0.00357	0.00762	CbGbCtD
Quinidine—ABCC2—Doxorubicin—prostate cancer	0.00338	0.00721	CbGbCtD
Quinidine—CYP2C9—Capecitabine—prostate cancer	0.00336	0.00718	CbGbCtD
Quinidine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00322	0.00688	CbGbCtD
Quinidine—CYP2E1—Etoposide—prostate cancer	0.00319	0.00682	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00303	0.00646	CbGbCtD
Quinidine—CYP3A7—Docetaxel—prostate cancer	0.00303	0.00646	CbGbCtD
Quinidine—CYP1A2—Estradiol—prostate cancer	0.00283	0.00604	CbGbCtD
Quinidine—ABCB1—Conjugated Estrogens—prostate cancer	0.00282	0.00601	CbGbCtD
Quinidine—CYP3A4—Cabazitaxel—prostate cancer	0.00264	0.00564	CbGbCtD
Quinidine—CYP3A4—Estrone—prostate cancer	0.00258	0.00551	CbGbCtD
Quinidine—ABCB1—Mitoxantrone—prostate cancer	0.00256	0.00547	CbGbCtD
Quinidine—CYP2C9—Estradiol—prostate cancer	0.00255	0.00544	CbGbCtD
Quinidine—ABCB1—Estradiol—prostate cancer	0.00247	0.00528	CbGbCtD
Quinidine—CYP2C8—Etoposide—prostate cancer	0.00239	0.00509	CbGbCtD
Quinidine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0023	0.00491	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—prostate cancer	0.00215	0.00459	CbGbCtD
Quinidine—ABCB1—Prednisone—prostate cancer	0.00213	0.00454	CbGbCtD
Quinidine—CYP1A2—Etoposide—prostate cancer	0.00185	0.00394	CbGbCtD
Quinidine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00169	0.0036	CbGbCtD
Quinidine—SLC22A8—urine—prostate cancer	0.00165	0.0492	CbGeAlD
Quinidine—ABCB1—Etoposide—prostate cancer	0.00161	0.00345	CbGbCtD
Quinidine—CYP3A4—Mitoxantrone—prostate cancer	0.00153	0.00328	CbGbCtD
Quinidine—CYP3A4—Estradiol—prostate cancer	0.00148	0.00316	CbGbCtD
Quinidine—ABCB1—Docetaxel—prostate cancer	0.00148	0.00315	CbGbCtD
Quinidine—KCNK1—prostate gland—prostate cancer	0.00129	0.0384	CbGeAlD
Quinidine—KCNK6—testis—prostate cancer	0.00128	0.0382	CbGeAlD
Quinidine—CYP3A4—Prednisone—prostate cancer	0.00127	0.00272	CbGbCtD
Quinidine—CYP1A2—urine—prostate cancer	0.00113	0.0337	CbGeAlD
Quinidine—ABCB1—Doxorubicin—prostate cancer	0.0011	0.00235	CbGbCtD
Quinidine—KCNK1—seminal vesicle—prostate cancer	0.00109	0.0325	CbGeAlD
Quinidine—CYP2C9—urine—prostate cancer	0.00107	0.032	CbGeAlD
Quinidine—CYP2D6—Doxorubicin—prostate cancer	0.00104	0.00222	CbGbCtD
Quinidine—CYP2E1—urine—prostate cancer	0.00102	0.0303	CbGeAlD
Quinidine—CYP3A4—Etoposide—prostate cancer	0.000968	0.00207	CbGbCtD
Quinidine—CYP3A4—Docetaxel—prostate cancer	0.000885	0.00189	CbGbCtD
Quinidine—KCNK1—renal system—prostate cancer	0.000879	0.0262	CbGeAlD
Quinidine—KCNK1—urethra—prostate cancer	0.000864	0.0257	CbGeAlD
Quinidine—CYP3A4—urine—prostate cancer	0.000818	0.0244	CbGeAlD
Quinidine—CYP2D6—urine—prostate cancer	0.000805	0.024	CbGeAlD
Quinidine—SCN3A—prostate gland—prostate cancer	0.000773	0.023	CbGeAlD
Quinidine—ORM1—prostate gland—prostate cancer	0.000703	0.021	CbGeAlD
Quinidine—SLC22A4—prostate gland—prostate cancer	0.000676	0.0202	CbGeAlD
Quinidine—CYP3A4—Doxorubicin—prostate cancer	0.00066	0.00141	CbGbCtD
Quinidine—CHRM2—prostate gland—prostate cancer	0.000656	0.0195	CbGeAlD
Quinidine—Quinine—SLC22A1—prostate cancer	0.000647	0.263	CrCbGaD
Quinidine—SLC22A2—renal system—prostate cancer	0.000622	0.0185	CbGeAlD
Quinidine—SLC22A8—prostate gland—prostate cancer	0.000592	0.0177	CbGeAlD
Quinidine—ABCC2—prostate gland—prostate cancer	0.000578	0.0172	CbGeAlD
Quinidine—SLC22A4—seminal vesicle—prostate cancer	0.000572	0.0171	CbGeAlD
Quinidine—KCNK1—testis—prostate cancer	0.000568	0.0169	CbGeAlD
Quinidine—SCN3A—renal system—prostate cancer	0.000527	0.0157	CbGeAlD
Quinidine—Quinine—CYP3A5—prostate cancer	0.000522	0.212	CrCbGaD
Quinidine—SLCO1B1—renal system—prostate cancer	0.000519	0.0155	CbGeAlD
Quinidine—ABCB11—testis—prostate cancer	0.000501	0.0149	CbGeAlD
Quinidine—KCNH2—prostate gland—prostate cancer	0.000474	0.0141	CbGeAlD
Quinidine—SLC22A4—renal system—prostate cancer	0.000461	0.0137	CbGeAlD
Quinidine—SLC22A5—prostate gland—prostate cancer	0.000448	0.0133	CbGeAlD
Quinidine—SLC22A1—renal system—prostate cancer	0.000439	0.0131	CbGeAlD
Quinidine—SLCO1A2—renal system—prostate cancer	0.000423	0.0126	CbGeAlD
Quinidine—KCNK1—lymph node—prostate cancer	0.000412	0.0123	CbGeAlD
Quinidine—SLC22A8—renal system—prostate cancer	0.000404	0.012	CbGeAlD
Quinidine—KCNH2—seminal vesicle—prostate cancer	0.000401	0.0119	CbGeAlD
Quinidine—SCN3A—bone marrow—prostate cancer	0.000398	0.0119	CbGeAlD
Quinidine—ABCC2—renal system—prostate cancer	0.000394	0.0117	CbGeAlD
Quinidine—SLC22A5—seminal vesicle—prostate cancer	0.000379	0.0113	CbGeAlD
Quinidine—CYP2E1—prostate gland—prostate cancer	0.000365	0.0109	CbGeAlD
Quinidine—ORM1—bone marrow—prostate cancer	0.000362	0.0108	CbGeAlD
Quinidine—Quinine—CYP2E1—prostate cancer	0.000359	0.146	CrCbGaD
Quinidine—Quinine—CYP2C19—prostate cancer	0.000355	0.144	CrCbGaD
Quinidine—Quinine—CYP1A1—prostate cancer	0.000354	0.144	CrCbGaD
Quinidine—SLC22A4—bone marrow—prostate cancer	0.000349	0.0104	CbGeAlD
Quinidine—SCN3A—testis—prostate cancer	0.00034	0.0101	CbGeAlD
Quinidine—KCNH2—renal system—prostate cancer	0.000323	0.00962	CbGeAlD
Quinidine—KCNH2—urethra—prostate cancer	0.000317	0.00945	CbGeAlD
Quinidine—CYP2E1—seminal vesicle—prostate cancer	0.000309	0.0092	CbGeAlD
Quinidine—SLC22A5—renal system—prostate cancer	0.000305	0.00909	CbGeAlD
Quinidine—SLC22A5—urethra—prostate cancer	0.0003	0.00893	CbGeAlD
Quinidine—CYP2C8—renal system—prostate cancer	0.000295	0.0088	CbGeAlD
Quinidine—CYP1A1—epithelium—prostate cancer	0.000294	0.00876	CbGeAlD
Quinidine—CYP1A2—renal system—prostate cancer	0.000276	0.00824	CbGeAlD
Quinidine—SLCO1A2—testis—prostate cancer	0.000273	0.00814	CbGeAlD
Quinidine—CYP1A1—renal system—prostate cancer	0.000273	0.00813	CbGeAlD
Quinidine—CYP1A1—urethra—prostate cancer	0.000268	0.00798	CbGeAlD
Quinidine—CYP2B6—renal system—prostate cancer	0.000265	0.0079	CbGeAlD
Quinidine—ABCC2—testis—prostate cancer	0.000255	0.00759	CbGeAlD
Quinidine—CYP2E1—renal system—prostate cancer	0.000249	0.00741	CbGeAlD
Quinidine—SCN3A—lymph node—prostate cancer	0.000247	0.00735	CbGeAlD
Quinidine—CYP2E1—urethra—prostate cancer	0.000244	0.00728	CbGeAlD
Quinidine—KCNH2—bone marrow—prostate cancer	0.000244	0.00728	CbGeAlD
Quinidine—Quinine—CYP3A4—prostate cancer	0.000226	0.0917	CrCbGaD
Quinidine—ORM1—lymph node—prostate cancer	0.000225	0.00669	CbGeAlD
Quinidine—SLC22A4—lymph node—prostate cancer	0.000216	0.00644	CbGeAlD
Quinidine—KCNH2—testis—prostate cancer	0.000209	0.00622	CbGeAlD
Quinidine—ABCB1—prostate gland—prostate cancer	0.000208	0.00619	CbGeAlD
Quinidine—CYP3A4—renal system—prostate cancer	0.0002	0.00596	CbGeAlD
Quinidine—SLC22A5—testis—prostate cancer	0.000197	0.00588	CbGeAlD
Quinidine—CYP2D6—renal system—prostate cancer	0.000197	0.00587	CbGeAlD
Quinidine—CYP2C8—testis—prostate cancer	0.000191	0.00569	CbGeAlD
Quinidine—ABCC2—lymph node—prostate cancer	0.000185	0.0055	CbGeAlD
Quinidine—ABCB1—seminal vesicle—prostate cancer	0.000176	0.00524	CbGeAlD
Quinidine—CYP2B6—testis—prostate cancer	0.000171	0.0051	CbGeAlD
Quinidine—CYP2E1—testis—prostate cancer	0.000161	0.00479	CbGeAlD
Quinidine—ABCB1—epithelium—prostate cancer	0.000153	0.00455	CbGeAlD
Quinidine—KCNH2—lymph node—prostate cancer	0.000151	0.00451	CbGeAlD
Quinidine—SLC22A5—lymph node—prostate cancer	0.000143	0.00426	CbGeAlD
Quinidine—ABCB1—renal system—prostate cancer	0.000142	0.00422	CbGeAlD
Quinidine—ABCB1—urethra—prostate cancer	0.000139	0.00415	CbGeAlD
Quinidine—CYP1A1—lymph node—prostate cancer	0.000128	0.00381	CbGeAlD
Quinidine—CYP2D6—testis—prostate cancer	0.000127	0.00379	CbGeAlD
Quinidine—ABCB1—bone marrow—prostate cancer	0.000107	0.00319	CbGeAlD
Quinidine—ABCB1—testis—prostate cancer	9.15e-05	0.00273	CbGeAlD
Quinidine—ABCB1—lymph node—prostate cancer	6.63e-05	0.00198	CbGeAlD
Quinidine—Pancytopenia—Doxorubicin—prostate cancer	4.29e-05	0.000373	CcSEcCtD
Quinidine—Renal failure—Epirubicin—prostate cancer	4.28e-05	0.000372	CcSEcCtD
Quinidine—Gastrointestinal disorder—Etoposide—prostate cancer	4.28e-05	0.000372	CcSEcCtD
Quinidine—Asthenia—Mitoxantrone—prostate cancer	4.27e-05	0.000372	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.26e-05	0.000371	CcSEcCtD
Quinidine—Jaundice—Epirubicin—prostate cancer	4.24e-05	0.000369	CcSEcCtD
Quinidine—Dizziness—Estradiol—prostate cancer	4.23e-05	0.000368	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—prostate cancer	4.22e-05	0.000367	CcSEcCtD
Quinidine—Sweating—Epirubicin—prostate cancer	4.17e-05	0.000363	CcSEcCtD
Quinidine—Chest pain—Capecitabine—prostate cancer	4.16e-05	0.000362	CcSEcCtD
Quinidine—Myalgia—Capecitabine—prostate cancer	4.16e-05	0.000362	CcSEcCtD
Quinidine—Confusional state—Docetaxel—prostate cancer	4.15e-05	0.000361	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.13e-05	0.000359	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—prostate cancer	4.12e-05	0.000359	CcSEcCtD
Quinidine—Oedema—Docetaxel—prostate cancer	4.12e-05	0.000358	CcSEcCtD
Quinidine—Vision blurred—Prednisone—prostate cancer	4.1e-05	0.000357	CcSEcCtD
Quinidine—Feeling abnormal—Etoposide—prostate cancer	4.08e-05	0.000355	CcSEcCtD
Quinidine—Diarrhoea—Mitoxantrone—prostate cancer	4.07e-05	0.000354	CcSEcCtD
Quinidine—Vomiting—Estradiol—prostate cancer	4.06e-05	0.000353	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—prostate cancer	4.06e-05	0.000353	CcSEcCtD
Quinidine—Gastrointestinal pain—Etoposide—prostate cancer	4.05e-05	0.000352	CcSEcCtD
Quinidine—Shock—Docetaxel—prostate cancer	4.05e-05	0.000352	CcSEcCtD
Quinidine—Nervous system disorder—Docetaxel—prostate cancer	4.04e-05	0.000351	CcSEcCtD
Quinidine—Thrombocytopenia—Docetaxel—prostate cancer	4.03e-05	0.000351	CcSEcCtD
Quinidine—Rash—Estradiol—prostate cancer	4.03e-05	0.00035	CcSEcCtD
Quinidine—Dermatitis—Estradiol—prostate cancer	4.03e-05	0.00035	CcSEcCtD
Quinidine—Confusional state—Capecitabine—prostate cancer	4.02e-05	0.000349	CcSEcCtD
Quinidine—Tachycardia—Docetaxel—prostate cancer	4.02e-05	0.000349	CcSEcCtD
Quinidine—Headache—Estradiol—prostate cancer	4e-05	0.000348	CcSEcCtD
Quinidine—Skin disorder—Docetaxel—prostate cancer	4e-05	0.000348	CcSEcCtD
Quinidine—Agitation—Prednisone—prostate cancer	4e-05	0.000348	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.99e-05	0.000347	CcSEcCtD
Quinidine—Oedema—Capecitabine—prostate cancer	3.99e-05	0.000347	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—prostate cancer	3.98e-05	0.000346	CcSEcCtD
Quinidine—Angioedema—Prednisone—prostate cancer	3.97e-05	0.000346	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—prostate cancer	3.96e-05	0.000344	CcSEcCtD
Quinidine—Urticaria—Etoposide—prostate cancer	3.93e-05	0.000342	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—prostate cancer	3.93e-05	0.000342	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—prostate cancer	3.93e-05	0.000341	CcSEcCtD
Quinidine—Anorexia—Docetaxel—prostate cancer	3.92e-05	0.000341	CcSEcCtD
Quinidine—Shock—Capecitabine—prostate cancer	3.92e-05	0.000341	CcSEcCtD
Quinidine—Body temperature increased—Etoposide—prostate cancer	3.92e-05	0.000341	CcSEcCtD
Quinidine—Abdominal pain—Etoposide—prostate cancer	3.92e-05	0.000341	CcSEcCtD
Quinidine—Nervous system disorder—Capecitabine—prostate cancer	3.91e-05	0.00034	CcSEcCtD
Quinidine—Vertigo—Prednisone—prostate cancer	3.91e-05	0.00034	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—prostate cancer	3.91e-05	0.00034	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—prostate cancer	3.91e-05	0.00034	CcSEcCtD
Quinidine—Thrombocytopenia—Capecitabine—prostate cancer	3.9e-05	0.000339	CcSEcCtD
Quinidine—Syncope—Prednisone—prostate cancer	3.9e-05	0.000339	CcSEcCtD
Quinidine—Tachycardia—Capecitabine—prostate cancer	3.89e-05	0.000338	CcSEcCtD
Quinidine—Skin disorder—Capecitabine—prostate cancer	3.87e-05	0.000337	CcSEcCtD
Quinidine—Sweating—Doxorubicin—prostate cancer	3.86e-05	0.000336	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—prostate cancer	3.86e-05	0.000336	CcSEcCtD
Quinidine—Hyperhidrosis—Capecitabine—prostate cancer	3.85e-05	0.000335	CcSEcCtD
Quinidine—Hypotension—Docetaxel—prostate cancer	3.85e-05	0.000335	CcSEcCtD
Quinidine—Urethral disorder—Epirubicin—prostate cancer	3.83e-05	0.000333	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—prostate cancer	3.82e-05	0.000332	CcSEcCtD
Quinidine—Anorexia—Capecitabine—prostate cancer	3.8e-05	0.00033	CcSEcCtD
Quinidine—Nausea—Estradiol—prostate cancer	3.8e-05	0.00033	CcSEcCtD
Quinidine—Vomiting—Mitoxantrone—prostate cancer	3.79e-05	0.000329	CcSEcCtD
Quinidine—Convulsion—Prednisone—prostate cancer	3.77e-05	0.000328	CcSEcCtD
Quinidine—Visual impairment—Epirubicin—prostate cancer	3.77e-05	0.000328	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—prostate cancer	3.76e-05	0.000327	CcSEcCtD
Quinidine—Rash—Mitoxantrone—prostate cancer	3.75e-05	0.000327	CcSEcCtD
Quinidine—Dermatitis—Mitoxantrone—prostate cancer	3.75e-05	0.000326	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.75e-05	0.000326	CcSEcCtD
Quinidine—Headache—Mitoxantrone—prostate cancer	3.73e-05	0.000324	CcSEcCtD
Quinidine—Hypotension—Capecitabine—prostate cancer	3.72e-05	0.000324	CcSEcCtD
Quinidine—Myalgia—Prednisone—prostate cancer	3.7e-05	0.000322	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—prostate cancer	3.69e-05	0.000321	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—prostate cancer	3.68e-05	0.00032	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.68e-05	0.00032	CcSEcCtD
Quinidine—Dyspnoea—Docetaxel—prostate cancer	3.67e-05	0.000319	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—prostate cancer	3.65e-05	0.000318	CcSEcCtD
Quinidine—Hypersensitivity—Etoposide—prostate cancer	3.65e-05	0.000317	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—prostate cancer	3.64e-05	0.000317	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—prostate cancer	3.63e-05	0.000316	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.63e-05	0.000316	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—prostate cancer	3.63e-05	0.000315	CcSEcCtD
Quinidine—Flushing—Epirubicin—prostate cancer	3.63e-05	0.000315	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—prostate cancer	3.62e-05	0.000314	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—prostate cancer	3.62e-05	0.000314	CcSEcCtD
Quinidine—Decreased appetite—Docetaxel—prostate cancer	3.58e-05	0.000311	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—prostate cancer	3.57e-05	0.000311	CcSEcCtD
Quinidine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Quinidine—Asthenia—Etoposide—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Quinidine—Dyspnoea—Capecitabine—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Quinidine—Oedema—Prednisone—prostate cancer	3.55e-05	0.000309	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—prostate cancer	3.54e-05	0.000308	CcSEcCtD
Quinidine—Nausea—Mitoxantrone—prostate cancer	3.54e-05	0.000308	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—prostate cancer	3.53e-05	0.000307	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—prostate cancer	3.52e-05	0.000306	CcSEcCtD
Quinidine—Chills—Epirubicin—prostate cancer	3.51e-05	0.000305	CcSEcCtD
Quinidine—Pruritus—Etoposide—prostate cancer	3.5e-05	0.000305	CcSEcCtD
Quinidine—Shock—Prednisone—prostate cancer	3.49e-05	0.000304	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—prostate cancer	3.48e-05	0.000303	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—prostate cancer	3.48e-05	0.000303	CcSEcCtD
Quinidine—Tachycardia—Prednisone—prostate cancer	3.46e-05	0.000301	CcSEcCtD
Quinidine—Decreased appetite—Capecitabine—prostate cancer	3.46e-05	0.000301	CcSEcCtD
Quinidine—Skin disorder—Prednisone—prostate cancer	3.45e-05	0.0003	CcSEcCtD
Quinidine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.44e-05	0.000299	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—prostate cancer	3.43e-05	0.000298	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—prostate cancer	3.42e-05	0.000298	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—prostate cancer	3.42e-05	0.000297	CcSEcCtD
Quinidine—Erythema—Epirubicin—prostate cancer	3.4e-05	0.000296	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—prostate cancer	3.4e-05	0.000296	CcSEcCtD
Quinidine—Feeling abnormal—Docetaxel—prostate cancer	3.39e-05	0.000295	CcSEcCtD
Quinidine—Diarrhoea—Etoposide—prostate cancer	3.39e-05	0.000295	CcSEcCtD
Quinidine—Anorexia—Prednisone—prostate cancer	3.38e-05	0.000294	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—prostate cancer	3.38e-05	0.000294	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—prostate cancer	3.37e-05	0.000293	CcSEcCtD
Quinidine—Gastrointestinal pain—Docetaxel—prostate cancer	3.37e-05	0.000293	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—prostate cancer	3.36e-05	0.000292	CcSEcCtD
Quinidine—Flushing—Doxorubicin—prostate cancer	3.36e-05	0.000292	CcSEcCtD
Quinidine—Feeling abnormal—Capecitabine—prostate cancer	3.28e-05	0.000286	CcSEcCtD
Quinidine—Dizziness—Etoposide—prostate cancer	3.28e-05	0.000285	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—prostate cancer	3.27e-05	0.000284	CcSEcCtD
Quinidine—Gastrointestinal pain—Capecitabine—prostate cancer	3.26e-05	0.000283	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—prostate cancer	3.26e-05	0.000283	CcSEcCtD
Quinidine—Body temperature increased—Docetaxel—prostate cancer	3.25e-05	0.000283	CcSEcCtD
Quinidine—Abdominal pain—Docetaxel—prostate cancer	3.25e-05	0.000283	CcSEcCtD
Quinidine—Chills—Doxorubicin—prostate cancer	3.24e-05	0.000282	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.23e-05	0.000281	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—prostate cancer	3.21e-05	0.000279	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—prostate cancer	3.17e-05	0.000276	CcSEcCtD
Quinidine—Urticaria—Capecitabine—prostate cancer	3.17e-05	0.000275	CcSEcCtD
Quinidine—Abdominal pain—Capecitabine—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Quinidine—Body temperature increased—Capecitabine—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Quinidine—Vomiting—Etoposide—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Quinidine—Erythema—Doxorubicin—prostate cancer	3.15e-05	0.000274	CcSEcCtD
Quinidine—Agitation—Epirubicin—prostate cancer	3.13e-05	0.000272	CcSEcCtD
Quinidine—Rash—Etoposide—prostate cancer	3.12e-05	0.000272	CcSEcCtD
Quinidine—Dermatitis—Etoposide—prostate cancer	3.12e-05	0.000271	CcSEcCtD
Quinidine—Headache—Etoposide—prostate cancer	3.1e-05	0.00027	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—prostate cancer	3.09e-05	0.000268	CcSEcCtD
Quinidine—Vertigo—Epirubicin—prostate cancer	3.06e-05	0.000266	CcSEcCtD
Quinidine—Syncope—Epirubicin—prostate cancer	3.05e-05	0.000265	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—prostate cancer	3.05e-05	0.000265	CcSEcCtD
Quinidine—Hypersensitivity—Docetaxel—prostate cancer	3.03e-05	0.000264	CcSEcCtD
Quinidine—Palpitations—Epirubicin—prostate cancer	3.01e-05	0.000261	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—prostate cancer	2.99e-05	0.00026	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—prostate cancer	2.97e-05	0.000258	CcSEcCtD
Quinidine—Asthenia—Docetaxel—prostate cancer	2.95e-05	0.000257	CcSEcCtD
Quinidine—Convulsion—Epirubicin—prostate cancer	2.95e-05	0.000256	CcSEcCtD
Quinidine—Nausea—Etoposide—prostate cancer	2.94e-05	0.000256	CcSEcCtD
Quinidine—Hypersensitivity—Capecitabine—prostate cancer	2.94e-05	0.000255	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—prostate cancer	2.93e-05	0.000254	CcSEcCtD
Quinidine—Pruritus—Docetaxel—prostate cancer	2.91e-05	0.000253	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—prostate cancer	2.9e-05	0.000252	CcSEcCtD
Quinidine—Myalgia—Epirubicin—prostate cancer	2.9e-05	0.000252	CcSEcCtD
Quinidine—Chest pain—Epirubicin—prostate cancer	2.9e-05	0.000252	CcSEcCtD
Quinidine—Agitation—Doxorubicin—prostate cancer	2.89e-05	0.000252	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.88e-05	0.00025	CcSEcCtD
Quinidine—Asthenia—Capecitabine—prostate cancer	2.86e-05	0.000249	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—prostate cancer	2.83e-05	0.000246	CcSEcCtD
Quinidine—Syncope—Doxorubicin—prostate cancer	2.82e-05	0.000246	CcSEcCtD
Quinidine—Urticaria—Prednisone—prostate cancer	2.82e-05	0.000245	CcSEcCtD
Quinidine—Pruritus—Capecitabine—prostate cancer	2.82e-05	0.000245	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—prostate cancer	2.82e-05	0.000245	CcSEcCtD
Quinidine—Diarrhoea—Docetaxel—prostate cancer	2.82e-05	0.000245	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—prostate cancer	2.81e-05	0.000244	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—prostate cancer	2.81e-05	0.000244	CcSEcCtD
Quinidine—Confusional state—Epirubicin—prostate cancer	2.8e-05	0.000243	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—prostate cancer	2.78e-05	0.000242	CcSEcCtD
Quinidine—Oedema—Epirubicin—prostate cancer	2.78e-05	0.000241	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—prostate cancer	2.77e-05	0.000241	CcSEcCtD
Quinidine—Shock—Epirubicin—prostate cancer	2.73e-05	0.000238	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—prostate cancer	2.73e-05	0.000237	CcSEcCtD
Quinidine—Diarrhoea—Capecitabine—prostate cancer	2.73e-05	0.000237	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—prostate cancer	2.72e-05	0.000237	CcSEcCtD
Quinidine—Dizziness—Docetaxel—prostate cancer	2.72e-05	0.000237	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—prostate cancer	2.72e-05	0.000236	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—prostate cancer	2.71e-05	0.000236	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—prostate cancer	2.7e-05	0.000235	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—prostate cancer	2.68e-05	0.000233	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—prostate cancer	2.68e-05	0.000233	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—prostate cancer	2.68e-05	0.000233	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.66e-05	0.000231	CcSEcCtD
Quinidine—Anorexia—Epirubicin—prostate cancer	2.65e-05	0.00023	CcSEcCtD
Quinidine—Dizziness—Capecitabine—prostate cancer	2.64e-05	0.000229	CcSEcCtD
Quinidine—Vomiting—Docetaxel—prostate cancer	2.62e-05	0.000228	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—prostate cancer	2.62e-05	0.000227	CcSEcCtD
Quinidine—Rash—Docetaxel—prostate cancer	2.6e-05	0.000226	CcSEcCtD
Quinidine—Hypotension—Epirubicin—prostate cancer	2.59e-05	0.000226	CcSEcCtD
Quinidine—Dermatitis—Docetaxel—prostate cancer	2.59e-05	0.000226	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—prostate cancer	2.59e-05	0.000225	CcSEcCtD
Quinidine—Headache—Docetaxel—prostate cancer	2.58e-05	0.000224	CcSEcCtD
Quinidine—Oedema—Doxorubicin—prostate cancer	2.57e-05	0.000223	CcSEcCtD
Quinidine—Asthenia—Prednisone—prostate cancer	2.55e-05	0.000222	CcSEcCtD
Quinidine—Vomiting—Capecitabine—prostate cancer	2.53e-05	0.00022	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.53e-05	0.00022	CcSEcCtD
Quinidine—Shock—Doxorubicin—prostate cancer	2.53e-05	0.00022	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—prostate cancer	2.52e-05	0.000219	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—prostate cancer	2.52e-05	0.000219	CcSEcCtD
Quinidine—Rash—Capecitabine—prostate cancer	2.51e-05	0.000219	CcSEcCtD
Quinidine—Pruritus—Prednisone—prostate cancer	2.51e-05	0.000218	CcSEcCtD
Quinidine—Dermatitis—Capecitabine—prostate cancer	2.51e-05	0.000218	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—prostate cancer	2.51e-05	0.000218	CcSEcCtD
Quinidine—Headache—Capecitabine—prostate cancer	2.5e-05	0.000217	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—prostate cancer	2.5e-05	0.000217	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—prostate cancer	2.48e-05	0.000216	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—prostate cancer	2.48e-05	0.000215	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—prostate cancer	2.45e-05	0.000213	CcSEcCtD
Quinidine—Nausea—Docetaxel—prostate cancer	2.44e-05	0.000213	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—prostate cancer	2.43e-05	0.000211	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—prostate cancer	2.41e-05	0.00021	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—prostate cancer	2.4e-05	0.000209	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.4e-05	0.000208	CcSEcCtD
Quinidine—Nausea—Capecitabine—prostate cancer	2.37e-05	0.000206	CcSEcCtD
Quinidine—Dizziness—Prednisone—prostate cancer	2.35e-05	0.000204	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.34e-05	0.000204	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—prostate cancer	2.29e-05	0.000199	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—prostate cancer	2.29e-05	0.000199	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—prostate cancer	2.27e-05	0.000197	CcSEcCtD
Quinidine—Vomiting—Prednisone—prostate cancer	2.26e-05	0.000196	CcSEcCtD
Quinidine—Rash—Prednisone—prostate cancer	2.24e-05	0.000195	CcSEcCtD
Quinidine—Dermatitis—Prednisone—prostate cancer	2.24e-05	0.000194	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—prostate cancer	2.23e-05	0.000194	CcSEcCtD
Quinidine—Headache—Prednisone—prostate cancer	2.22e-05	0.000193	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.22e-05	0.000193	CcSEcCtD
Quinidine—Urticaria—Epirubicin—prostate cancer	2.21e-05	0.000192	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—prostate cancer	2.19e-05	0.000191	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—prostate cancer	2.19e-05	0.000191	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—prostate cancer	2.12e-05	0.000184	CcSEcCtD
Quinidine—Nausea—Prednisone—prostate cancer	2.11e-05	0.000183	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.1e-05	0.000183	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—prostate cancer	2.05e-05	0.000178	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—prostate cancer	2.04e-05	0.000177	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—prostate cancer	2.03e-05	0.000177	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—prostate cancer	2.03e-05	0.000177	CcSEcCtD
Quinidine—Asthenia—Epirubicin—prostate cancer	1.99e-05	0.000173	CcSEcCtD
Quinidine—Pruritus—Epirubicin—prostate cancer	1.96e-05	0.000171	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—prostate cancer	1.9e-05	0.000165	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—prostate cancer	1.89e-05	0.000165	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—prostate cancer	1.84e-05	0.00016	CcSEcCtD
Quinidine—Dizziness—Epirubicin—prostate cancer	1.84e-05	0.00016	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—prostate cancer	1.82e-05	0.000158	CcSEcCtD
Quinidine—Vomiting—Epirubicin—prostate cancer	1.77e-05	0.000154	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—prostate cancer	1.76e-05	0.000153	CcSEcCtD
Quinidine—Rash—Epirubicin—prostate cancer	1.75e-05	0.000152	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—prostate cancer	1.75e-05	0.000152	CcSEcCtD
Quinidine—Headache—Epirubicin—prostate cancer	1.74e-05	0.000151	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—prostate cancer	1.7e-05	0.000148	CcSEcCtD
Quinidine—Nausea—Epirubicin—prostate cancer	1.65e-05	0.000143	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—prostate cancer	1.63e-05	0.000142	CcSEcCtD
Quinidine—Rash—Doxorubicin—prostate cancer	1.62e-05	0.000141	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—prostate cancer	1.62e-05	0.000141	CcSEcCtD
Quinidine—Headache—Doxorubicin—prostate cancer	1.61e-05	0.00014	CcSEcCtD
Quinidine—Nausea—Doxorubicin—prostate cancer	1.53e-05	0.000133	CcSEcCtD
Quinidine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—MTHFR—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TYMS—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.09e-06	1.11e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BAD—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTM1—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARA—prostate cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—prostate cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—LPL—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CA—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APC—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ACHE—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GGT1—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—prostate cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGF—prostate cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.03e-06	1.06e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TYMS—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—INS—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP1A1—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TYMS—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ERCC2—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—EP300—prostate cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CAV1—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CREBBP—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—INS—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PRKACB—prostate cancer	1e-06	1.02e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—LPL—prostate cancer	1e-06	1.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—INS—prostate cancer	9.93e-07	1.01e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—LPL—prostate cancer	9.93e-07	1.01e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP17A1—prostate cancer	9.91e-07	1.01e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CREBBP—prostate cancer	9.9e-07	1.01e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—RXRA—prostate cancer	9.81e-07	1e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—prostate cancer	9.76e-07	9.96e-06	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—prostate cancer	9.74e-07	9.95e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	9.73e-07	9.93e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.68e-07	9.88e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP1A1—prostate cancer	9.67e-07	9.87e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IGF1—prostate cancer	9.6e-07	9.81e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ERCC2—prostate cancer	9.59e-07	9.79e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.59e-07	9.79e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CD—prostate cancer	9.58e-07	9.78e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MTHFR—prostate cancer	9.57e-07	9.77e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	9.56e-07	9.76e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.54e-07	9.74e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—INS—prostate cancer	9.53e-07	9.73e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ERCC2—prostate cancer	9.51e-07	9.71e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—COMT—prostate cancer	9.45e-07	9.65e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NCOA2—prostate cancer	9.44e-07	9.64e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—prostate cancer	9.4e-07	9.6e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARA—prostate cancer	9.39e-07	9.58e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CD—prostate cancer	9.38e-07	9.58e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CREBBP—prostate cancer	9.33e-07	9.53e-06	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—EP300—prostate cancer	9.31e-07	9.5e-06	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—EP300—prostate cancer	9.29e-07	9.49e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	9.28e-07	9.48e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ITPR1—prostate cancer	9.25e-07	9.45e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—prostate cancer	9.23e-07	9.42e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	9.22e-07	9.41e-06	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	9.13e-07	9.33e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	9.12e-07	9.31e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.1e-07	9.29e-06	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—prostate cancer	9.08e-07	9.27e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—NOS3—prostate cancer	9.05e-07	9.24e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	9.03e-07	9.22e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MTHFR—prostate cancer	9.02e-07	9.2e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.01e-07	9.2e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MTHFR—prostate cancer	8.94e-07	9.12e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—NOS3—prostate cancer	8.86e-07	9.05e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CD—prostate cancer	8.85e-07	9.03e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARA—prostate cancer	8.84e-07	9.03e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGF2—prostate cancer	8.83e-07	9.01e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CAV1—prostate cancer	8.82e-07	9.01e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.8e-07	8.98e-06	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CA—prostate cancer	8.77e-07	8.95e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARA—prostate cancer	8.77e-07	8.95e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TYMS—prostate cancer	8.74e-07	8.93e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—INS—prostate cancer	8.73e-07	8.92e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOS3—prostate cancer	8.71e-07	8.89e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NQO1—prostate cancer	8.7e-07	8.88e-06	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—EP300—prostate cancer	8.66e-07	8.84e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTM1—prostate cancer	8.64e-07	8.82e-06	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—prostate cancer	8.58e-07	8.76e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TH—prostate cancer	8.58e-07	8.76e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CREBBP—prostate cancer	8.55e-07	8.73e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—LPL—prostate cancer	8.48e-07	8.66e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—JAK2—prostate cancer	8.46e-07	8.64e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—NOS3—prostate cancer	8.35e-07	8.53e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CB—prostate cancer	8.35e-07	8.53e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.34e-07	8.52e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CAV1—prostate cancer	8.32e-07	8.49e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	8.29e-07	8.47e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—prostate cancer	8.27e-07	8.45e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MDM2—prostate cancer	8.26e-07	8.43e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CAV1—prostate cancer	8.24e-07	8.42e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP1A1—prostate cancer	8.19e-07	8.36e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CB—prostate cancer	8.18e-07	8.35e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	8.14e-07	8.32e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ERCC2—prostate cancer	8.12e-07	8.3e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.11e-07	8.28e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—prostate cancer	8.1e-07	8.27e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GGT1—prostate cancer	8.08e-07	8.25e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—prostate cancer	8.04e-07	8.21e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	8.04e-07	8.21e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NCOA1—prostate cancer	7.96e-07	8.13e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.88e-07	8.04e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.84e-07	8.01e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	7.72e-07	7.89e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CB—prostate cancer	7.71e-07	7.87e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NOS3—prostate cancer	7.66e-07	7.82e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—prostate cancer	7.64e-07	7.8e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MTHFR—prostate cancer	7.64e-07	7.8e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—INS—prostate cancer	7.61e-07	7.77e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—prostate cancer	7.57e-07	7.73e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—RXRA—prostate cancer	7.57e-07	7.73e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	7.54e-07	7.7e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.51e-07	7.67e-06	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	7.5e-07	7.66e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARA—prostate cancer	7.49e-07	7.65e-06	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	7.46e-07	7.62e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CREBBP—prostate cancer	7.45e-07	7.61e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—prostate cancer	7.39e-07	7.55e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—prostate cancer	7.38e-07	7.54e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—prostate cancer	7.34e-07	7.5e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—COMT—prostate cancer	7.29e-07	7.44e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—prostate cancer	7.26e-07	7.41e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—prostate cancer	7.22e-07	7.37e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—prostate cancer	7.2e-07	7.35e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—INS—prostate cancer	7.17e-07	7.32e-06	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—prostate cancer	7.16e-07	7.31e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ITPR1—prostate cancer	7.14e-07	7.29e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	7.13e-07	7.28e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—INS—prostate cancer	7.11e-07	7.26e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.07e-07	7.22e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—prostate cancer	7.07e-07	7.22e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CD—prostate cancer	7.07e-07	7.21e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CAV1—prostate cancer	7.04e-07	7.19e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CREBBP—prostate cancer	7.02e-07	7.17e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—prostate cancer	7e-07	7.15e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—prostate cancer	6.99e-07	7.13e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CREBBP—prostate cancer	6.96e-07	7.11e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	6.96e-07	7.11e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—prostate cancer	6.95e-07	7.09e-06	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CA—prostate cancer	6.88e-07	7.03e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—EP300—prostate cancer	6.88e-07	7.03e-06	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CA—prostate cancer	6.87e-07	7.02e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	6.78e-07	6.92e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TYMS—prostate cancer	6.75e-07	6.89e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—EP300—prostate cancer	6.74e-07	6.88e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.73e-07	6.87e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NOS3—prostate cancer	6.67e-07	6.81e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTM1—prostate cancer	6.67e-07	6.81e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—prostate cancer	6.66e-07	6.8e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CD—prostate cancer	6.66e-07	6.8e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EP300—prostate cancer	6.62e-07	6.76e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.6e-07	6.74e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—LPL—prostate cancer	6.55e-07	6.68e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SRC—prostate cancer	6.44e-07	6.58e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—prostate cancer	6.42e-07	6.55e-06	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CA—prostate cancer	6.41e-07	6.54e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—EP300—prostate cancer	6.35e-07	6.49e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.32e-07	6.46e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NOS3—prostate cancer	6.29e-07	6.42e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	6.27e-07	6.4e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ERCC2—prostate cancer	6.27e-07	6.4e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NOS3—prostate cancer	6.23e-07	6.36e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—prostate cancer	6.21e-07	6.34e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CB—prostate cancer	6.16e-07	6.29e-06	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—prostate cancer	6.13e-07	6.26e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—prostate cancer	6.11e-07	6.24e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—prostate cancer	6.1e-07	6.23e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—INS—prostate cancer	6.07e-07	6.2e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CREBBP—prostate cancer	5.95e-07	6.07e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MTHFR—prostate cancer	5.89e-07	6.02e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—EP300—prostate cancer	5.83e-07	5.95e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.8e-07	5.93e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARA—prostate cancer	5.78e-07	5.9e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—prostate cancer	5.77e-07	5.89e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	5.76e-07	5.88e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.75e-07	5.87e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—prostate cancer	5.75e-07	5.87e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—prostate cancer	5.7e-07	5.82e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—prostate cancer	5.65e-07	5.76e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CD—prostate cancer	5.64e-07	5.76e-06	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—prostate cancer	5.62e-07	5.74e-06	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—prostate cancer	5.61e-07	5.73e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CAV1—prostate cancer	5.44e-07	5.55e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—prostate cancer	5.33e-07	5.45e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NOS3—prostate cancer	5.33e-07	5.44e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—prostate cancer	5.32e-07	5.43e-06	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—prostate cancer	5.23e-07	5.34e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CA—prostate cancer	5.09e-07	5.2e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—EP300—prostate cancer	5.08e-07	5.18e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—prostate cancer	5.02e-07	5.12e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CA—prostate cancer	4.99e-07	5.09e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—prostate cancer	4.97e-07	5.08e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.95e-07	5.06e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.92e-07	5.02e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	4.9e-07	5e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—prostate cancer	4.87e-07	4.97e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—EP300—prostate cancer	4.78e-07	4.88e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—EP300—prostate cancer	4.74e-07	4.84e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—prostate cancer	4.74e-07	4.84e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CA—prostate cancer	4.7e-07	4.8e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—INS—prostate cancer	4.69e-07	4.79e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CREBBP—prostate cancer	4.59e-07	4.69e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.35e-07	4.44e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—prostate cancer	4.34e-07	4.43e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.31e-07	4.4e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—prostate cancer	4.25e-07	4.34e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—prostate cancer	4.16e-07	4.25e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NOS3—prostate cancer	4.11e-07	4.2e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—prostate cancer	4.07e-07	4.16e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—EP300—prostate cancer	4.05e-07	4.14e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—prostate cancer	4e-07	4.09e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—prostate cancer	3.84e-07	3.92e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.79e-07	3.87e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.76e-07	3.84e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CA—prostate cancer	3.75e-07	3.83e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.54e-07	3.61e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—prostate cancer	3.52e-07	3.59e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.51e-07	3.58e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—prostate cancer	3.28e-07	3.35e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—EP300—prostate cancer	3.13e-07	3.19e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—prostate cancer	3.07e-07	3.13e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CA—prostate cancer	3e-07	3.06e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—prostate cancer	2.89e-07	2.95e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—prostate cancer	2.87e-07	2.93e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—prostate cancer	2.45e-07	2.5e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.31e-07	2.36e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—prostate cancer	1.89e-07	1.93e-06	CbGpPWpGaD
